Wisconsin Alumni Research Foundation

Technology

Nuclease Inhibitors and Methods for Their Use

Biochemical research and biotechnology rely on nucleic acids; however, nucleic acids frequently encounter nucleases that can negatively affect experiments. Although nuclease inhibitors are often used ...
Learn More
Ronald Raines, Bryan Smith, David Lynn, Matthew Soellner | P05096US

Technology

Cytotoxic Ribonuclease Variants

Ribonucleases are enzymes that catalyze the degradation of RNA. Levels of RNase activity are controlled in vivo by a ribonuclease inhibitor (RI), which binds strongly to an RNase to completely inhibit...
Learn More
Ronald Raines, Julie Mitchell, Thomas Rutkoski | P04427US

Technology

Hyperstable Collagen Mimics

Collagen, the most abundant protein in vertebrates, serves as the fundamental structural protein for vertebrate tissues. Collagen is a fibrous protein consisting of three polypeptide chains that fold ...
Learn More
Ronald Raines, Jonathan Hodges | P03226US

Technology

Stable Collagen Mimics

Collagen, the most abundant protein in vertebrates, provides structure for tissues and plays a key role in wound healing. In connective tissue, individual collagen molecules are wound together in tigh...
Learn More
Ronald Raines, Matthew Shoulders, Jonathan Hodges | P06406US

Technology

Improving Drug Delivery with Boronic Acids

The utility of many biologic drugs is limited by inefficient delivery into cells. Strategies to overcome this limitation have included enhancing the attraction between positively charged drug agents a...
Learn More
Ronald Raines, Gregory Ellis, Michael Palte | P110315US02

Technology

Improved Disulfide-Bond Reducing Agents

Disulfide bonds between cysteine residues are the most common crosslinking agents in proteins. Reducing these bonds is an ordinary procedure in biochemistry and biotechnology. The most commonly used r...
Learn More
Ronald Raines, John Lukesh | P110330US02

Technology

Bioreversible Boronates Improve Drug Delivery

The utility of many biologic drugs is limited by inefficient delivery into cells. Strategies to overcome this limitation have included enhancing the attraction between positively charged drug agents a...
Learn More
Ronald Raines, Thomas Smith | P150009US02

Technology

Inhibitors Of Collagen Prolyl 4-Hydroxylase

The invention provides biheteroaryl dicarboxylates and esters, and salts thereof which are useful generally as modulators of CP4H activity, more particularly as inhibitors of CP4H, or further as chemi...
Learn More
Ronald Raines, James Vasta | P150092US02

Technology

Enhancing Cell Penetration to Improve Drug Delivery

The utility of many biologic drugs is limited by inefficient cellular delivery. There is a particular need for methods and reagents that facilitate delivery of peptides and proteins into the interior ...
Learn More
Ronald Raines, Kristen Andersen | P150031US02

Technology

New Disulfide-Bond Reducing Agent

Disulfide bonds between cysteine residues are the most common crosslinking agents in proteins. Reducing these bonds is an ordinary procedure in biochemistry and biotechnology. The most commonly used r...
Learn More
Ronald Raines, John Lukesh | P140284US01

Technology

Bioreversible Protein Esterification

Proteins contain carboxyl groups. These charged groups make it difficult for any protein to enter a human (or other eukaryotic) cell. Modifying proteins to enter cells could revolutionize medicine, e....
Learn More
Ronald Raines, Nicholas McGrath | P130148US02

Technology

Protecting Groups for Boronic Acids

Boronic acids (i.e., compounds that have a single boron-carbon bond) are one of the most useful functional groups in organic chemistry and chemical biology. They have applications in polymer sciences,...
Learn More
Ronald Raines, Brett VanVeller, Matthew Aronoff | P130142US02

WARF